Table 1.
Characteristics of the African Cohort Study women who received high-risk human papilloma virus genotyping (n = 1002).
Characteristic | n (column %) | High-risk HPV not detected [n (column %)] | High-risk HPV detected [n (column %)] | ∗P value |
Age (years) | 0.329 | |||
18–24 | 50 (5.0%) | 19 (3.7%) | 31 (6.3%) | |
25–39 | 430 (42.9%) | 221 (43.4%) | 209 (42.4%) | |
40–49 | 347 (34.6%) | 178 (35.0%) | 169 (34.3%) | |
≥50 | 175 (17.5%) | 91 (17.9%) | 84 (17.0%) | |
Site, country | 0.143 | |||
Kayunga, Uganda | 98 (9.8%) | 56 (11.0%) | 42 (8.5%) | |
South Rift Valley, Kenya | 447 (44.6%) | 237 (46.6%) | 210 (42.6%) | |
Kisumu West, Kenya | 107 (10.7%) | 58 (11.4%) | 49 (9.9%) | |
Mbeya, Tanzania | 230 (22.9%) | 103 (20.2%) | 127 (25.8%) | |
Abuja, Nigeria | 62 (6.2%) | 26 (5.1%) | 36 (7.3%) | |
Lagos, Nigeria | 58 (5.8%) | 29 (5.7%) | 29 (5.9%) | |
Education | 0.962 | |||
No formal education | 36 (3.6%) | 19 (3.7%) | 17 (3.4%) | |
≤Primary | 256 (25.5%) | 131 (25.7%) | 125 (25.3%) | |
≥Secondary | 710 (70.9%) | 359 (70.5%) | 351 (71.2%) | |
Age at 1st sexual intercourse | 0.293 | |||
≤18 | 701 (71.0%) | 349 (69.4%) | 352 (72.6%) | |
>18 | 287 (29.0%) | 154 (30.6%) | 133 (27.4%) | |
Missing | 14 | 6 | 8 | |
Number of lifetime sexual partners | 0.541 | |||
No partner | 323 (32.4%) | 164 (32.3%) | 159 (32.4%) | |
One partner | 595 (59.6%) | 307 (60.6%) | 288 (58.7%) | |
Multiple (≥two) partners | 80 (8.0%) | 36 (7.1%) | 44 (9.0%) | |
Missing | 4 | 2 | 2 | |
HIV status | 0.007 | |||
Women living without HIV | 134 (13.4%) | 83 (16.3%) | 51 (10.3%) | |
Women living with HIV | 868 (86.6%) | 426 (83.7%) | 442 (89.7%) | |
HIV-associated parameters (among WLWH only) | ||||
On ART | 0.010 | |||
Yes | 844 (97.3%) | 420 (98.8%) | 424 (95.9%) | |
No | 23 (2.7%) | 5 (1.2%) | 18 (4.1%) | |
Missing | 1 | 1 | 0 | |
CD4+ cell count (cells/μl) | <0.001 | |||
≤200 | 57 (6.7%) | 14 (3.4%) | 43 (9.9%) | |
201–500 | 311 (36.7%) | 142 (34.2%) | 169 (39.0%) | |
>500 | 480 (56.6%) | 259 (62.4%) | 221 (51.0%) | |
Missing | 20 | 11 | 9 | |
HIV viral load (copies/ml) | 0.010 | |||
≤1000 | 772 (89.7%) | 391 (92.4%) | 381 (87.0%) | |
>1000 | 89 (10.3%) | 32 (7.6%) | 57 (13.0%) | |
Missing | 7 | 3 | 4 |
P values were calculated using Pearson's chi-squared test. Statistically significant P values (P < 0.05) are in bold.